KK
BBNX

Kotler Kevin’s Beta Bionics BBNX Stock Holding History

Kotler Kevin’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$250K Buy
+8,216
New +$219K 0.06% 33

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Kotler Kevin's BBNX Position: Q4 2025 in Review

Kotler Kevin opened a new position in Beta Bionics (BBNX) in Q4 2025: 8,216 shares worth $250K. The stake represents 0.06% of the portfolio and ranks #33 among its holdings.

158 funds tracked by Wall St. Rank hold BBNX as of Q4 2025.

  • Kotler Kevin held 8,216 shares of Beta Bionics worth $250K as of Q4 2025.
  • Beta Bionics was a new Kotler Kevin position in Q4 2025.
  • Beta Bionics made up 0.06% of Kotler Kevin's portfolio in Q4 2025, its #33 holding.
  • 158 funds tracked by Wall St. Rank held Beta Bionics as of Q4 2025.

Based on Kotler Kevin's 13F filing for Q4 2025, filed 17 Feb 2026.